XML 38 R16.htm IDEA: XBRL DOCUMENT v3.23.2
Income Taxes
 12 Months Ended
Mar. 31, 2023
Income Taxes [Abstract]  
INCOME TAXES

NOTE 9 – INCOME TAXES

 

The income tax provision consisted of the following:

 

   Year Ended March 31, 
   2023   2022 
Current portion:        
Federal  $
—
   $
—
 
State   1,600    1,600 
    1,600    1,600 
Deferred portion:          
Federal   (2,933,000)   (4,109,000)
State   (1,467,000)   (1,300,000)
    (4,400,000)   (5,409,000)
Change in valuation allowance   4,400,000    5,409,000 
Provision for income taxes  $1,600   $1,600 

 

At March 31, 2023, the Company had net operating loss carryforwards (NOLs) of approximately $29,500,000 for federal income tax purposes and $36,600,000 for state income tax purposes. These NOLs are available to reduce future taxable income and will expire at various times from 2037 through 2043, except federal NOLs from fiscal 2018 and later, which will never expire.

 

The Company also had federal research and development tax credit carryforwards of approximately $1,300,000, which will begin expiring at various times from 2038 through 2042, and state research and development credits of approximately $400,000, which do not have an expiration date.

 

A reconciliation of income taxes provided at the federal statutory rate to the actual income tax provision is as follows:

 

 

   Year Ended March 31, 
   2023   2022 
Federal statutory rate   (21)%   (21)%
State tax rate, net of federal benefit   (6)%   (7)%
Research and development tax credits   (6)%   (2)%
Change in valuation allowance   29%   30%
Other   4%   
—
%
Effective income tax rate   
—
%   
—
%

 

The losses before income tax provision for the years ended March 31, 2023 and 2022 were solely attributable to US operations. Significant components of the Company’s deferred tax assets and liabilities were:

 

   March 31, 
   2023   2022 
Net operating loss carryforwards  $8,742,000   $7,731,000 
Stock-based compensation expense   2,587,000    1,824,000 
Property and equipment   105,000    80,000 
Reserves, accruals & other   1,841,000    (104,000)
Research and development tax credits   1,658,000    988,000 
Total deferred tax assets   14,933,000    10,519,000 
Section 179 assets   (111,000)   (97,000)
Total deferred tax liabilities   (111,000)   (97,000)
Less: valuation allowance   (14,822,000)   (10,422,000)
Deferred tax assets, net  $—   $— 

 

Based on the available information and other factors, management believes it is more likely than not that the net deferred tax assets at March 31, 2023 and 2022, will not be fully realizable. Accordingly, management has recorded a full valuation allowance against its net deferred tax assets at March 31, 2023 and 2022.

 

Management has evaluated and concluded that there were no material uncertain tax positions requiring recognition in the Company’s consolidated financial statements at March 31, 2023 and 2022. The Company does not expect any significant changes in its unrecognized tax benefits within twelve months of the reporting date.